Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPRA | P18433 | 1/20 | 0.82 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.67 |
| ▸ | TSHR | P16473 | 2/20 | 0.67 |
| ▸ | BLM | P54132 | 2/20 | 0.67 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.67 |
| ▸ | HTR1A | P08908 | 1/20 | 0.67 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.67 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.67 |
| ▸ | HTR2A | P28223 | 1/20 | 0.67 |
| ▸ | HTR2C | P28335 | 1/20 | 0.67 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.67 |
| ▸ | HTR7 | P34969 | 1/20 | 0.67 |
| ▸ | HTR2B | P41595 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1580111 | 1.00 | PTPRA (0.82) | PTPRACYP2C19KMT2AKDM4ELMNA | |
| Gamma-Aminobutyric Acid SCHEMBL3789958 | 0.90 | PTPRA (0.68) | PTPRACYP2C19KMT2AKDM4ELMNA | |
| SCHEMBL30789181 | 0.90 | PTPRA (1.00) | PTPRACYP2C19KMT2AKDM4ELMNA | |
| SCHEMBL30381729 | 0.90 | PTPRA (1.00) | PTPRACYP2C19KMT2AKDM4ELMNA | |
| SCHEMBL2965137 | 0.90 | PTPRA (1.00) | PTPRACYP2C19KMT2AKDM4ELMNA | |
| SCHEMBL3519524 | 0.90 | PTPRA (1.00) | PTPRACYP2C19KMT2AKDM4ELMNA | |
| SCHEMBL145392 | 0.90 | PTPRA (1.00) | PTPRACYP2C19KMT2AKDM4ELMNA | |
| SCHEMBL5115727 | 0.90 | PTPRA (0.67) | PTPRACYP2C19KMT2AKDM4ELMNA | |
| SCHEMBL5115733 | 0.90 | PTPRA (0.67) | PTPRACYP2C19KMT2AKDM4ELMNA | |
| SCHEMBL5773295 | 0.86 | PTPRA (0.61) | PTPRACYP2C19KMT2AKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3788149-B1 | A METHOD FOR OPTIMIZING ANTIBODY EXPRESSION | AMBRX INC (US) | 2025-08-27 | — | — | EP | claimed |
| EP-3630977-B1 | METHODS AND COMPOSITIONS FOR PROMOTING NON-NATURAL AMINO ACID-CONTAINING PROTEIN PRODUCTION | AMBRX INC (US) | 2024-02-21 | — | — | EP | claimed |
| US-20260060959-A1 | FORMULATIONS WITH REDUCED OXIDATION | GENENTECH INC (US) | 2026-03-05 | — | — | US | disclosed |
| US-20260002147-A1 | ENGINEERED SYNTHASE FOR PRODUCTION OF TRYPTOPHAN DERIVATIVES AND INTRANSIGENT SUBSTRATES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2026-01-01 | — | — | US | disclosed |
| EP-4651906-A1 | ANTI-CD70 ANTIBODY-DRUG CONJUGATES | Ambrx, Inc. (US) | 2025-11-26 | — | — | EP | disclosed |
| EP-4598586-A1 | DRUG LINKERS AND ANTIBODY CONJUGATES THEREOF | Ambrx, Inc. (US) | 2025-08-13 | — | — | EP | disclosed |
| US-12385029-B2 | Engineered synthase for production of tryptophan derivatives and intransigent substrates | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2025-08-12 | — | — | US | disclosed |
| WO-2025041055-A1 | ANTI-PSMA ADC CONJUGATE COMPOSITIONS AND METHODS OF USE THEREOF | AMBRX, INC. (US) | 2025-02-27 | — | — | WO | disclosed |
| WO-2024241086-A1 | PEGYLATED BOVINE INTERFERON LAMBDA AND METHODS OF USE THEREOF | AMBRX, INC. (US) | 2024-11-28 | — | — | WO | disclosed |
| WO-2024215515-A1 | DRUG LINKERS AND ANTIBODY CONJUGATES THEREOF | AMBRX, INC. (US) | 2024-10-17 | — | — | WO | disclosed |
| WO-2024178310-A1 | TROP2-DIRECTED ANTIBODY-DRUG CONJUGATES AND USES THEREOF | AMBRX, INC. (US) | 2024-08-29 | — | — | WO | disclosed |
| WO-1998051331-A1 | SOMATOSTATIN AND SOMATOSTATIN AGONISTS FOR DECREASING BODY WEIGHT | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES S.A. (S.C.R.A.S.) (FR) | 1998-11-19 | — | — | WO | disclosed |
| WO-1998008529-A1 | METHOD OF INHIBITING FIBROSIS WITH A SOMATOSTATIN AGONIST | BIOMEASURE INCORPORATED (US) | 1998-03-05 | — | — | WO | disclosed |
| US-5686418-A | SOMATOSTATIN | BIOMEASURE INCORPORATED (US) | 1997-11-11 | — | — | US | disclosed |
| US-5583104-A | SOMATOSTATIN ANTITUMOR AGENTS | MAYO FOUNDATION FOR MEDICAL RESEARCH AND EDUCATION (US) | 1996-12-10 | — | — | US | disclosed |
| US-5504069-A | USING SOMATOSTATIN | BIOMEASURE, INC. (US) | 1996-04-02 | — | — | US | disclosed |
| EP-0644893-A4 | INHIBITION OF TRAUMA-INDUCED TUMOR GROWTH. | BIOMEASURE INC (US) | 1995-09-20 | — | — | EP | disclosed |
| EP-0657174-A1 | Use of somatostatin | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 1995-06-14 | — | — | EP | disclosed |
| EP-0644893-A1 | INHIBITION OF TRAUMA-INDUCED TUMOR GROWTH | BIOMEASURE, INC. (US) | 1995-03-29 | — | — | EP | disclosed |
| WO-1994018231-A1 | INHIBITION OF TRAUMA-INDUCED TUMOR GROWTH | BIOMEASURE, INC. (US) | 1994-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060959-A1 | FORMULATIONS WITH REDUCED OXIDATION | LPO, SET, PTMS | PTPRA 2900/4885CYP2C19 599/4885KMT2A 3872/4885 |
| US-12385029-B2 | Engineered synthase for production of tryptophan derivatives and intransigent substrates | WARS1, TPH1, TPH2 | PTPRA 3344/4885CYP2C19 1937/4885KMT2A 1560/4885 |
| US-20260002147-A1 | ENGINEERED SYNTHASE FOR PRODUCTION OF TRYPTOPHAN DERIVATIVES AND INTRANSIGENT SUBSTRATES | INMT, TPH1, TPH2 | PTPRA 4506/4885CYP2C19 110/4885KMT2A 1052/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.